ARCHIVES

ACS Says 41 Percent Survive 5 Years

This article is from The Cancer Letter archive.

Vol. 07 No. 01 | January 2, 1981

Download PDF Visit The Full Archive

Related Articles

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002

NC-Approved Clinical Trials

June 27, 2003

New Center Plan Discussed By NAB, Directors Committees

May 4, 1990

NIH Reauthorization Threatened By Fetal Research Issue

October 5, 1990

NCI Cooperative Group, Cancer Center Trials Listed

November 25, 2005

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997